找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Combination Therapy in Urological Malignancy; Philip H. Smith (Consultant Urologist) Book 1989 Springer-Verlag Berlin Heidelberg 1989 Stag

[復(fù)制鏈接]
查看: 49965|回復(fù): 57
樓主
發(fā)表于 2025-3-21 16:05:53 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Combination Therapy in Urological Malignancy
編輯Philip H. Smith (Consultant Urologist)
視頻videohttp://file.papertrans.cn/230/229861/229861.mp4
叢書名稱Clinical Practice in Urology
圖書封面Titlebook: Combination Therapy in Urological Malignancy;  Philip H. Smith (Consultant Urologist) Book 1989 Springer-Verlag Berlin Heidelberg 1989 Stag
描述Any discussion of the present success in management of urological cancers evokes a mixed response. Oncologists and urologists can enjoy the success with chemotherapy for testicular cancers but cannot forget the dismal results with any form of treatment, other than surgery, for renal carcinoma. But these are the less frequent urolegi- cal tumours: what are the attitudes to the more common prostate and bladder cancers. Intensive study, many clinical trials and much debate lead us to the conclusion that we understand them better, we can tailor the treatment more appropriately to the individual patient but there remains some uncertainty as to the overall success that we have achieved. There have been no striking changes in the 5-year survival data. Clinicians tend to see their success in terms of their special interest. Radiotherapists point to their success in stage-reduction but what are we to do with the many patients whose tumour is unaltered by radiotherapy. Urological surgeons, and especially those who are still influenced by the shadow of Halsted, point to their success in excising the cancer but apart from that highly selected group, what are we to do for the very large number
出版日期Book 1989
關(guān)鍵詞Staging; Tumor; cancer; carcinoma; chemotherapy; clinical trial; immunotherapy; kidney; metastatic disease; o
版次1
doihttps://doi.org/10.1007/978-1-4471-1655-4
isbn_softcover978-1-4471-1657-8
isbn_ebook978-1-4471-1655-4Series ISSN 0177-8994
issn_series 0177-8994
copyrightSpringer-Verlag Berlin Heidelberg 1989
The information of publication is updating

書目名稱Combination Therapy in Urological Malignancy影響因子(影響力)




書目名稱Combination Therapy in Urological Malignancy影響因子(影響力)學(xué)科排名




書目名稱Combination Therapy in Urological Malignancy網(wǎng)絡(luò)公開度




書目名稱Combination Therapy in Urological Malignancy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Combination Therapy in Urological Malignancy被引頻次




書目名稱Combination Therapy in Urological Malignancy被引頻次學(xué)科排名




書目名稱Combination Therapy in Urological Malignancy年度引用




書目名稱Combination Therapy in Urological Malignancy年度引用學(xué)科排名




書目名稱Combination Therapy in Urological Malignancy讀者反饋




書目名稱Combination Therapy in Urological Malignancy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:11:07 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:28:28 | 只看該作者
地板
發(fā)表于 2025-3-22 07:38:21 | 只看該作者
Management of Invasive Bladder Neoplasms, any tumour that extends beyond the in situ category, urologically it implies muscle infiltration and uniform recommendations concerning management are lacking. Once infiltration is documented, the ability to control the disease by transurethral resection diminishes, thus, radical surgery, with or w
5#
發(fā)表于 2025-3-22 10:22:56 | 只看該作者
,Carcinoma of the Prostate — Non-metastatic Disease,In 1988, approximately 99 000 new cases of prostate cancer will be diagnosed in the United States and approximately 28 000 men will die from it (Silverberg and Lubern 1988). It is a disease of ageing men and with the increasing age of the male population worldwide, prostate cancer is expected to bec
6#
發(fā)表于 2025-3-22 15:13:32 | 只看該作者
7#
發(fā)表于 2025-3-22 19:21:40 | 只看該作者
Cancer of the Penis, disease which has . been exclusively managed by urological surgeons and oncologists. In its early stages it may be seen and treated by such diverse clinicians as venereologists, dermatologists, general surgeons, radiotherapists and general practitioners. Few doctors, indeed few Oncology Centres, ha
8#
發(fā)表于 2025-3-22 21:31:39 | 只看該作者
Clinical Trials in Genitourinary Oncology: What Have They Achieved?, experience of the clinician recommending treatment, his time and place of training, and his awareness of the results of clinical trials which have addressed aspects of management relevant to this particular patient. A recent survey of practice relating to urological cancer has demonstrated very div
9#
發(fā)表于 2025-3-23 03:04:03 | 只看該作者
10#
發(fā)表于 2025-3-23 09:03:45 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 22:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
靖安县| 鄯善县| 连州市| 合肥市| 沈丘县| 乌拉特前旗| 雅江县| 新郑市| 开化县| 合水县| 黔西县| 濮阳县| 呼伦贝尔市| 禄劝| 旬阳县| 灌南县| 绥阳县| 浮山县| 东兴市| 五台县| 安化县| 龙里县| 漾濞| 如皋市| 云安县| 陇西县| 独山县| 德格县| 成都市| 阆中市| 安龙县| 汉源县| 宁都县| 邵阳市| 嘉鱼县| 洮南市| 沧州市| 司法| 永寿县| 桂阳县| 宝山区|